Working the night shift can wreak havoc on your health in just a few days, a study from Washington State University reveals.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

a diabetes researcher at the University of Melbourne. The next generation of drugs will target specific conditions associated with diabetes and obesity, such as sleep apnoea, fatty liver disease, ...